JP Morgan Chase
RBOT

JP Morgan Chase’s Vicarious Surgical RBOT Stock Holding History

JP Morgan Chase’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-81
Closed -$176 – 7825
2025
Q4 		$176 Sell
81
-5
-6% -$20 ﹤0.01% 7178
2025
Q3 		$474 Sell
86
-2
-2% -$15 ﹤0.01% 7057
2025
Q2 		$661 Buy
88
+7
+9% +$51 ﹤0.01% 6667
2025
Q1 		$531 Sell
81
-3,450
-98% -$40.8K ﹤0.01% 6698
2024
Q4 		$46.5K Buy
3,531
+2,044
+137% +$21K ﹤0.01% 6045
2024
Q3 		$8.45K Buy
1,487
+1,406
+1,736% +$9.34K ﹤0.01% 6397
2024
Q2 		$475 Sell
81
-4,054
-98% -$36.3K ﹤0.01% 6692
2024
Q1 		$37.4K Buy
4,135
+1,304
+46% +$15.6K ﹤0.01% 6042
2023
Q4 		$31.1K Buy
2,831
+1,313
+86% +$14.6K ﹤0.01% 6144
2023
Q3 		$26.9K Sell
1,518
-347
-19% -$12.6K ﹤0.01% 5990
2023
Q2 		$102K Buy
1,865
+450
+32% +$28.7K ﹤0.01% 5445
2023
Q1 		$96K Buy
1,415
+382
+37% +$29.7K ﹤0.01% 5447
2022
Q4 		$62K Buy
1,033
+39
+4% +$3.63K ﹤0.01% 5540
2022
Q3 		$100K Buy
994
+22
+2% +$2.56K ﹤0.01% 5290
2022
Q2 		$86K Buy
972
+281
+41% +$34.3K ﹤0.01% 5482
2022
Q1 		$105K Sell
691
-264
-28% -$49.1K ﹤0.01% 5483
2021
Q4 		$304K Buy
+955
New +$337K ﹤0.01% 5127

Other funds holding RBOT

AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
FFG
Forum Finance Group Geneva $184M AUM
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

JP Morgan Chase's RBOT Position: Q1 2026 in Review

JP Morgan Chase sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 81 shares — an estimated $176 sold.

JP Morgan Chase first reported a position in RBOT in Q4 2021 and held it in 17 quarters. The position peaked at $304K in Q4 2021. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • JP Morgan Chase reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 81 Vicarious Surgical shares in Q1 2026, an estimated $176.
  • JP Morgan Chase first reported a position in Vicarious Surgical in Q4 2021 and held it in 17 quarters.
  • JP Morgan Chase's Vicarious Surgical position peaked at $304K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.